Effects of tyroservatide on histone acetylation in lung carcinoma cells.
Xu
Qiong
Q
Department of Immunology, Tianjin Medical University, Tianjin, China.
Lu
Rong
R
Zhu
Zhi-Feng
ZF
Lv
Jun-Qiang
JQ
Wang
Li-Juan
LJ
Zhang
Wen
W
Hu
Jin-Wei
JW
Meng
Jie
J
Lin
Gang
G
Yao
Zhi
Z
D000107:Acetylation; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002453:Cell Cycle / Q000187:drug effects; D045744:Cell Line, Tumor; D049109:Cell Proliferation / Q000187:drug effects; D050759:Cyclin-Dependent Kinase Inhibitor p21 / Q000032:analysis / Q000235:genetics; D050760:Cyclin-Dependent Kinase Inhibitor p27; D051548:Histone Acetyltransferases / Q000378:metabolism; D056572:Histone Deacetylase Inhibitors / Q000494:pharmacology; D006655:Histone Deacetylases / Q000378:metabolism; D006657:Histones / Q000378:metabolism*; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins / Q000032:analysis / Q000235:genetics; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology; D009842:Oligopeptides / Q000494:pharmacology*
D000970:Antineoplastic Agents; C493956:CDKN1A protein, human; C436291:CDKN1B protein, human; D050759:Cyclin-Dependent Kinase Inhibitor p21; D056572:Histone Deacetylase Inhibitors; D006657:Histones; D047908:Intracellular Signaling Peptides and Proteins; D009842:Oligopeptides; C510683:tripeptide tyroservatide; D050760:Cyclin-Dependent Kinase Inhibitor p27; D051548:Histone Acetyltransferases; D006655:Histone Deacetylases